CT Kapital OÜ
Acquisition of majority share in biotech company
Abgeschlossen
- Deadline14.04.2017
- Beginn der Anlageperiode13.04.2017
- Startzeit07.04.2017 07:00
- AnlageklasseFUSIONEN UND ÜBERNAHMEN
- InvestitionsartAndere
- Enddatum der Investition12.04.2019
- Anlagehorizont linksÜberfällig 90+ Tage
- Erwartete Rendite15.8% p.a
- Erwartete Barrendite%
- Anzahl der Investoren502
- Ziel€450 000
Kurzfassung
CT Kapital OÜ is a SPV established for the acquisiton of majority share in biotechnology company Cellin Technologies OÜ. The acquisition is to be financed with a 150,000 euros of owner's equity and a 450,000 euro crowdfunded loan facility.
The crowdfunded capital layer is structured as secured 2-year loan with a fixed annual interest rate of 15% . The loan pays quarterly interest and returns principal proportionally on 12th, 18th and 24th month.
Investment's IRR is 15.8%.
